Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-22T15:46:15.378Z Has data issue: false hasContentIssue false
  • English
  • Français

The Nucleus Basalis of Meynert

Published online by Cambridge University Press:  18 September 2015

Cheryl Ezrin-Waters  and
L. Resch
Cheryl Ezrin-Waters*
Affiliation:
Department of Neuropathology, Toronto Western Hospital, University of Toronto
L. Resch
Affiliation:
Department of Neuropathology, Toronto Western Hospital, University of Toronto
*
Neurology Program, Addiction Research Foundation, 33 Russell Street, Toronto, Ontario, Canada M5S 2S1
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The nucleus basalis of Meynert has been studied extensively in the recent literature. Interest in this nucleus has resulted from the discovery that it is a major source of cortical cholinergic input and that there is neuronal loss in the nucleus basalis in some dementing illnesses. Consistent and severe involvement of the nucleus basalis of Meynert has been found in Alzheimer's disease and in the dementia accompanying Parkinson's disease. Occasional involvement is present in other dementing illnesses, such as progressive supranuclear palsy, Parkinsonism-Dementia complex of Guam, dementia pugilistica, Pick's disease, Korsakoff's syndrome, Down's Syndrome and Creutzfeldt- Jakob disease. Huntington's disease spares this nucleus. However, the role of the nucleus in cognitive function is as yet undetermined. Even its alteration with normal aging remains controversial. This review details the pathological studies of this region to date, with particular emphasis on the dementias. Its role in the dementias of Alzheimer's disease and Parkinson's disease is specifically addressed.

Type
Special Features
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue 1 , February 1986 , pp. 8 - 14
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

REFERENCES

1.Whitehouse, PJ.Theodor Meynert: Foreshadowing modern concepts of neuropsychiatrie pathophysiology. Neurology 1985;35: 389–393.CrossRefGoogle Scholar
2.Külliker, A.Handbuch der Gewebelehre des Menschen. Vol 2 Nervensystem 1896; Leipzig: Engelmann.Google Scholar
3.Mesulam, MM, Mufson, EJ, Levey, ALet al. Cholinergic innvervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey. J Comp Neurol 1983; 214: 170–197.CrossRefGoogle Scholar
4.Lewy, FH.Zur pathologischen Anatomie der Paralysis Agitans. Dtsch Z Nervenheilkd 1913; 50: 50–55.Google Scholar
5.Von Buttlar-Brentano, K.Das Parkinsinsyndrom im Lichte der lebensgeshichtlichen Veranderungen des Nucleus Basalis. J Hirnforsch 1955; 2: 55–76.Google Scholar
6.Hedreen, JC, Struble, RG, Whitehouse, PJet al. Topography of the magnocellular basal forebrain system in human brain. J Neuropath Exp Neurol 1984; 43: 1–21.CrossRefGoogle ScholarPubMed
7.Whitehouse, PJ, Price, DL, Clark, AWet al. Alzheimer Disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10: 122–126.CrossRefGoogle ScholarPubMed
8.Whitehouse, PJ, Price, DL, Struble, RGet al. Alzheimer’s Disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237–1239.CrossRefGoogle ScholarPubMed
9.Jones, EG, Burton, H, Saper, CBet al. Midbrain diencephalic and cortical relationships of the nucleus basalis of Meynert and associated structrures in primates. J Comp Neurol 1976; 167: 385–397.CrossRefGoogle Scholar
10.Coyle, JT, Price, DL, DeLong, MR.Alzheimer’s Disease: a disorder of cortical cholinergic innervation. Science 1983:219:1184–1190.CrossRefGoogle ScholarPubMed
11.Johnston, MV, McKinney, M., Coyle, J.Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci USA 1979; 76:5392–5396.CrossRefGoogle ScholarPubMed
12.Lehmann, J, Nagy, JI, Atmadja, Set al. The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat. Neuroscience 1980; 5: 1161–1174.CrossRefGoogle Scholar
13.McGeer, PL, McGeer, EG, Singh, VKet al. Cholineacetyltransferase localization in the central nervous system by immunohisto-chemistry. Brain Res 1974; 81: 373–379.CrossRefGoogle Scholar
14.Hattori, T, Singh, VK, McGeer, EGet al. Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses. Brain Res 1976; 102: 164–173.CrossRefGoogle ScholarPubMed
15.Kimura, H, McGeer, PL, Peng, JHet al. The central cholinergic system studied by choline acetyltransferase immunohistochem-istry in the cat. J Comp Neurol 1981; 200: 151–201.CrossRefGoogle Scholar
16.Hebb, CO, Krnjevic, K, Silver, A.Effect of undercutting on the acetylcholinestrase and choline acetyltransferase activity in the cat’s cerebral cortex. Nature 1963; 198: 692.CrossRefGoogle Scholar
17.Parent, A, Gravel, S, Olivier, A.The extrapyramidal and limbic systems relationship at the globus pallidus level: a comparative histochemical study in the rat, cat, and monkey. Adv Neurol 1979; 24: 1–24.Google Scholar
18.Perry, RH, Candy, JM, Perry, EKet al. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat 1984; 138(4): 713–732.Google ScholarPubMed
19.Drachman, DA.Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 1977; 27: 783–790.CrossRefGoogle ScholarPubMed
20.Drachman, DA, Leavitt, J.Human memory and the cholinergic system. A relationship to aging? Arch Neurol 1974; 30: 113–121.CrossRefGoogle ScholarPubMed
21.Peters, BH, Levin, HS.Effects of physostigmine and lecithin on memory in Alzheimer Disease. Ann Neurol 1979; 6: 219–221.CrossRefGoogle ScholarPubMed
22.Davis, KL, Mohs, RC, Tinklenberg, JRet al. Physostigmine: improvement of long-term memory processes in normal humans. Science 1978; 201: 272–274.CrossRefGoogle ScholarPubMed
23.Perry, EK, Tomlinson, BE, Blessed, Get al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Brit Med J 1978; 2: 1457–1459.CrossRefGoogle ScholarPubMed
24.Lo Conte, G, Bartolini, K, Casamenti, Fet al. Lesions of cholinergic forebrain nuclei: changes in avoidance behaviour and scopolamine actions. Pharmacol Biochem Behav 1982; 17: 933–937.CrossRefGoogle ScholarPubMed
25.Flicker, C, Dean, RL, Watkins, DLet al. Behavioural and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav 1983; 18: 973–981.CrossRefGoogle Scholar
26.Hepler, DJ, Olton, DS, Wenk, GLet al. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J Neurosci 1985; 5:866–873.CrossRefGoogle ScholarPubMed
27.Davies, P, Maloney, AJR. Selective loss of central cholinergic neurons in Alzheimer’s Disease. Lancet 1976; 2: 1403.CrossRefGoogle ScholarPubMed
28.Perry, EK, Perry, RH, Blessed, Get al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977; 1: 189.CrossRefGoogle ScholarPubMed
29.White, P, Goodhardt, MJ, Keet, JP, et al. Neocortical cholinergic neurons in elderly people. Lancet 1977; 1: 668–671.CrossRefGoogle ScholarPubMed
30.Arendt, T, Bigl, V, Arendt, A, et al. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s Disease, Paralysis Agitans and Korsakoff’s Disease. Acta Neuropathologica 1983; 61:101–108.CrossRefGoogle ScholarPubMed
31.Candy, JM, Perry, RH, Perry, EKet al. Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s Disease. J Neurol Sci 1983; 54 (59): 277–289.CrossRefGoogle Scholar
32.Tagliavini, F, Pilleri, G.Basal Nucleus of Meynert. A neuropathological study in Alzheimer’s Disease, simple senile dementia, Pick’s Disease and Huntington’s Chorea. J Neurol Sci 1983; 62: 243–260.CrossRefGoogle ScholarPubMed
33.Whitehouse, PJ, Hedreen, JC, White, CL III, et al. Neuronal loss in the basal forebrain cholinergic system is more marked in Alzheimer’s Disease than in senile dementia of the Alzheimer type. (Abstract) Ann Neurol 1983; 10: 149.Google Scholar
34.Wilcox, GR, Esiri, MM, Bowen, DMet al. The Nucleus Basalis in Alzheimer’s Disease. Cell counts and cortical biochemistry. Neuropath Appl Neurobiol 1983;9: 175–179.Google Scholar
35.Mann, DMA, Yates, PO, Marcyniuk, B.Alzheimer’s presenile dementia, senile dementia of the Alzheimer type and Down’s Sydrome in middle age form an age related continuum of pathological changes. Neuropath Appl Neurobiol 1984; 10: 185–207.CrossRefGoogle Scholar
36.Rogers, JD, Brogan, D, Mirra, SS.The nucleus basalis of Meynert in neurological disease. A quantitative morphological study. Ann Neurol 1985; 17: 163–171.CrossRefGoogle ScholarPubMed
37.Mann, DMA.Nerve cell protein metabolism and degenerative disease. Neuropath Appl Neurobiol 1982; 8: 161–176.CrossRefGoogle ScholarPubMed
38.Whitehouse, PJ, Struble, RG, Clark, AWet al. Alzheimer Disease: plaques, tangles and the basal forebrain. (Letter) Ann Neurol 1982; 12: 494.CrossRefGoogle ScholarPubMed
39.Whitehouse, PJ, Hedreen, JC, Jones, BEet al. A computer analysis of neuronal size in the nucleus basalis of Meynert in patients with Alzheimer’s Disease. (Abstract) Ann Neurol 1983; 10: 149.Google Scholar
40.Lloyd, KG, Mohler, H, Heitz, P, et al. Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinson’s Disease. J Neurochem 1975; 25: 789–795.CrossRefGoogle Scholar
41.McGeer, PL, McGeer, EG.Enzymes associated with the metabolism of catecholamines, acetycholine and GABA in human controls and patients with Parkinson’s Disease and Huntington’s Chorea. J Neurochem 1976; 26: 65–76.CrossRefGoogle Scholar
42.Clark, AW, Parhad, IM, Folstein, SEet al. The nucleus basalis in Huntington’s Disease. Neurology 1983; 33: 1262–1267.CrossRefGoogle ScholarPubMed
43.Averback, P.Lesions of the nucleus ansae peduncularis in neuropsychiatrie disease. Arch Neurol 1981; 230–235.CrossRefGoogle Scholar
44.Whitehouse, PJ, Hedreen, JC, White, CL IIIet al. Basal forebrain neurons in the dementia of Parkinson’s Disease. Ann Neurol 1983; 13: 243–248.CrossRefGoogle Scholar
45.Gaspar, P., Gray, F.Dementia in idiopathic Parkinson’s Disease. Acta Neuropathol (Berl) 1984; 64: 43–52.CrossRefGoogle ScholarPubMed
46.Nakano, I, Hirano, A.Parkinson’s Disease: neuron loss in the nucleus basalis without concomitant Alzheimer’s Disease. Ann Neurol 1984; 15: 415–418.CrossRefGoogle ScholarPubMed
47.Pendlebury, WW, Perl, DP.Nucleus basalis of Meynert: severe cell loss in Parkinson’s Disease without dementia. (Abstract) Ann Neurol 1984: 16: 129.Google Scholar
48.Tagliavini, F, Pilleri, G, Bouras, Cet al. The basal nucleus of Meynert in idiopathic Parkinson’s Disease. Acta Neurol Scand 1984; 69: 20–28.Google Scholar
49.Whitehouse, PJ, Parhard, IM, Hedreen, JCet al. Integrity of the nucleus basalis of Meynert in normal aging. (Abstract) Neurology (Suppl 2) 1983; 33: 159.Google Scholar
50.McGeer, PL, McGeer, EG, Suzuki, Jet al. Aging, Alzheimer’s Disease, and the cholinergic system of the basal forebrain. Neurology 1984; 34: 741–745.CrossRefGoogle ScholarPubMed
51.Tagliavini, F, Pilleri, G, Bouras, Cet al. The basal nucleus of Meynert in patients with progressive supranuclear palsy. Neurosci Lett 1984; 44: 37–42.CrossRefGoogle ScholarPubMed
52.Nakano, I, Hirano, A.Neuron loss in the nucleus basalis of Meynert in Parkinsonism-Dementia complex of Guam. Ann Neurol 1983; 13: 87–91.CrossRefGoogle ScholarPubMed
53.Uhl, GR, McKinney, M, Hedreen, JCet al. Dementia Pugilistica: loss of basal forebrain cholinergic neurons and cortical cholinergic markers. (Abstract) Ann Neurol 1982; 12: 99.Google Scholar
54.Uhl, GR, Hilt, DC, Hedreen, JC.Pick’s Disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology 1983; 33: 1470–1473.CrossRefGoogle ScholarPubMed
55.Munoz-Garcia, D, Ludwin, SR.Classic and generalized variants of Pick’s Disease. A clinicopathological, ultrastructural, and im-munocytochemical Comparative Study. Ann Neurol 1984; 16: 467–480.CrossRefGoogle ScholarPubMed
56.Price, DL, Whitehouse, PJ, Struble, RGet al. Alzheimer’s Disease and Down’s Syndrome. Ann NY Acad Sci 1982; 396: 145–164.CrossRefGoogle ScholarPubMed
57.Casanova, MF, Walker, LC, Whitehouse, PJet al. Abnormalities of the nucleus basalis in Down’s Syndrome. Ann Neurol 1985; 18: 310–313.CrossRefGoogle ScholarPubMed
58.Kirkpatrick, JB, Hicks, P.Nucleus basalis in Down’s Syndrome. J Neuropath Exp Neurol 1984; 43: 307.CrossRefGoogle Scholar
59.Clark, AW, Lehmann, J, Whitehouse, PJ.Cortico-striato-spinal degen- eration (CSSD) mimicking Alzheimer’s Disease: Studies of the nucleus basalis of Meynert and cortical choline acetyltransferase. (Abstract) J Neuropath Exp Neurol 1983; 42: 334.CrossRefGoogle Scholar
60.Horoupian, DS, Thai, L, Katzman, Ret al. Dementia and motor neuron disease: morphometric, biochemical, and golgi studies. Ann Neurol 1984; 16: 305–313.CrossRefGoogle ScholarPubMed
61.Arendt, T, Bigl, V, Arendt, A.Neurone loss in the nucleus basalis in Meynert in Creutzfeldt-Jakob Disease. Acta Neuropath 1984; 65(1): 85–88.CrossRefGoogle ScholarPubMed
62.Struble, RG, Cork, LC, Whitehouse, PJ, et al. Cholinergic innervation in neuritic plaques. Science 1982; 216: 413–414.CrossRefGoogle ScholarPubMed